SD Biosensor, Inc. (KRX:137310)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,150.00
+10.00 (0.14%)
At close: Jun 12, 2026

SD Biosensor Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-470,727-512,106-98,411-467,712911,3621,088,471
Depreciation & Amortization
130,464134,266141,694137,54140,82019,115
Loss (Gain) From Sale of Assets
-6,077-7,748-4,0921,0451,8041,373
Asset Writedown & Restructuring Costs
753,790753,790135,26299,8698,6342,283
Loss (Gain) From Sale of Investments
-6,887-530.9412,378-4,046-3,107-9,480
Loss (Gain) on Equity Investments
15,14115,1553,532986.912,560-2,802
Stock-Based Compensation
11,121803.15905.39969.115,55918,867
Provision & Write-off of Bad Debts
-2,023-923.756,9764,0579,6401,319
Other Operating Activities
-8,27122,884-24,055-33,212-31,661224,801
Change in Accounts Receivable
-23,871-29,3709,636-5,17762,516185,970
Change in Inventory
-15,974-10,303-5,89681,644-28,60435,418
Change in Accounts Payable
27,41619,6358,069-31,006-36,683-304,205
Change in Other Net Operating Assets
-34,018-28,037-29,472-27,277-63,831-26,185
Operating Cash Flow
370,083357,516156,527-242,319889,0081,234,945
Operating Cash Flow Growth
188.57%128.41%---28.01%149.29%
Capital Expenditures
-54,636-57,086-78,783-142,566-301,999-190,053
Sale of Property, Plant & Equipment
86,49086,3819,5682,9622,915731.12
Cash Acquisitions
-7,922-8,066--1,748,595-47,154-36,764
Divestitures
--565.25---
Sale (Purchase) of Intangibles
-310.7-403.73-2,118-1,864-3,248-1,980
Investment in Securities
102,382-155,268-260,670-16,366706,574-901,853
Other Investing Activities
-26,049860.71-7,649-6,1002,658169,690
Investing Cash Flow
94,611-139,944-338,926-1,912,529359,745-960,569
Short-Term Debt Issued
-3,059--81,679-
Long-Term Debt Issued
-14,93313,640835,483--
Total Debt Issued
7,09817,99313,640835,48381,679-
Short-Term Debt Repaid
--1,940-133,468-255,617-81,695-1,765
Long-Term Debt Repaid
--8,042-8,041-13,822-11,623-4,968
Total Debt Repaid
-392,523-9,982-141,509-269,439-93,319-6,733
Net Debt Issued (Repaid)
-385,4258,011-127,869566,044-11,640-6,733
Issuance of Common Stock
-164.82-227,6042,383507,472
Repurchase of Common Stock
-0-11,575-18,425---99,644
Dividends Paid
-24,164-24,183-38.07-29,550-198,735-49,831
Other Financing Activities
-1,667067.35,664-17,7452,839
Financing Cash Flow
-411,256-27,582-146,266769,762-225,737354,102
Foreign Exchange Rate Adjustments
1,774-633.5623,705-5,476-31,6659,899
Net Cash Flow
55,213189,356-304,960-1,390,561991,351638,377
Free Cash Flow
315,447300,43177,744-384,884587,0081,044,892
Free Cash Flow Growth
434.93%286.44%---43.82%137.22%
Free Cash Flow Margin
43.89%42.28%11.19%-58.70%20.02%35.66%
Free Cash Flow Per Share
2637.042510.42635.94-3471.825794.8110714.52
Cash Interest Paid
25,30925,68431,85559,592984.72497.84
Cash Income Tax Paid
--338,038-84,493198,926537,064132,849
Levered Free Cash Flow
-27,452-44,627-93,587-250,134402,401766,104
Unlevered Free Cash Flow
36,06223,014-50,719-219,366403,022766,410
Change in Working Capital
-46,448-48,074-17,66218,183-66,603-109,001